Global Diaphragm Pacing Device Market, By Product (External Diaphragm Pacemaker and Internal Diaphragm Pacemaker), Application (Spinal Cord Injuries (SCI)), (Amyotrophic Lateral Sclerosis (ALS)), Chronic Pain, Parkinson’s Disease, Urine Incontinence, Epilepsy) – Industry Trends and Forecast to 2029.
Diaphragm Pacing Device Market Analysis and Size
Diaphragm pacing (DP) is a useful and cost-effective alternative to mechanical ventilation in patients with ventilator-dependent spinal cord injury and central hypoventilation syndrome. Patients with spinal cord injuries should be carefully screened to assess the integrity of their phrenic nerves. In eligible patients, diaphragm pacing improves mobility, speech, olfaction, and quality of life. Another, albeit uncommon, application of diaphragm pacing is to treat patients who have intractable hiccups.
Data Bridge Market Research analyses that the diaphragm pacing device market which was USD 4 million in 2021, is expected to reach USD 6.09 million by 2029, at a CAGR of 5.40% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Diaphragm Pacing Device Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (External Diaphragm Pacemaker and Internal Diaphragm Pacemaker), Application (Spinal Cord Injuries (SCI)), (Amyotrophic Lateral Sclerosis (ALS)), Chronic Pain, Parkinson’s Disease, Urine Incontinence, Epilepsy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Unicare (U.S.), Mayo Foundation for Medical Education and Research (MFMER) (U.S.), Wellmark Inc. (U.S.), Avery Biomedical Devices, Inc. (U.S.), Lungpacer Medical Inc (Canada), Diaphragm Direct (U.S.), Splashtop Inc (U.S.), DYI SHENG INDUSTRY CO.LTD (Taiwan), Ningbo Yokey Precision Technology Co.Ltd (China), ZHONGDE (BEIJING) MACHINERY EQUIPMENT CO,LTD (China), TexRAD Limited (U.S.), Arrow Safety Device (U.S.), Device Technologies, Inc (U.S.), Lungpacer Medical Inc. (Canada), Avery Biomedical Devices, Inc. (U.S.), Synapse Biomedical (U.S.), Atrotech (Germany), Medtronic (Ireland)
|
|
Market Opportunities
|
|
Market Definition
Diaphragm pacing system (DPS) is a treatment option for patients who are unable to breathe on their own and rely on a ventilator. The DPS can provide part-time or full-time respiratory support to people who would otherwise require a mechanical ventilator to breathe. Diaphragm pacing (also known as phrenic pacing) is a method of providing ventilatory support to patients with chronic respiratory insufficiency who have limited function of their diaphragm, lungs, and phrenic nerves. It is typically far less expensive than the mechanical alternative and may provide a significantly higher quality of life.
Global Diaphragm Pacing Device Market Dynamics
Drivers
- Increasing prevalence of spinal cord injuries and amyotrophic lateral sclerosis
The increasing prevalence of SCI (Spinal Cord Injuries) and rising occurrences of ALS are the key market driving factors of the global diaphragm pacing device market. According to the National Spinal Cord Injury Statistical Center report for 2019, nearly 17,730 new SCI cases are accounted for each year, and approximately 249,000 to 363,000 people are currently surviving with SCI in the United States. Furthermore, the global market is exhibiting significant growth as a result of rising technological advancements as well as rising product innovations and launches in the segment to fuel market growth. The market is driving due to the numerous benefits associated with diaphragm pacing device, such as less reliance on mechanical ventilators and allowing patients to breathe more efficiently and naturally without the use of ventilators.
- Rising use of diaphragm pacing device in developing economies
Uses of diaphragm pacing device for a range of purposes such as improvement of speech and breathing in patients and reduction of the dependency on mechanical ventilators will act as a driver for the growth of the market. External diaphragm pacemaker market is gaining popularity as it is used in the treatment of congenital central hypoventilation syndrome and cervical spinal cord injury. As diaphragm pacemaker reduces the concerns of power outages and external power source which drives the growth of the market.
Opportunities
- Increasing mobility in the patients is a determinant
DP improves mobility, speech, olfaction, and quality of life. The stigma of being attached to a mechanical device and risk of ventilator disconnection are eliminated. Decline in respiratory infections and increasing mobility in the patients are also drive the growth of the external diaphragm pacemaker market and also will create growth opportunities for diaphragm pacing device market in the forecast period of 2022-2029.
Restraints/Challenges
- High costs to restrain the market growth
A diaphragm wall requires heavy and complicated precast elements which make it expensive. Some people have trouble inserting the diaphragm, and it can take practice to get comfortable doing it. Diaphragms can get moved out of place if there's a lot of hard thrusting going on.
This diaphragm pacing device market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diaphragm pacing device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Diaphragm Pacing Device Market Scope
The diaphragm pacing device market is segmented on the basis of product and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- External Diaphragm Pacemaker
- Internal Diaphragm Pacemaker
Application
- Spinal Cord Injuries (SCI)
- Amyotrophic Lateral Sclerosis (ALS)
- Parkinson’s Disease
- Urine Incontinence
- Epilepsy
Diaphragm Pacing Device Market Regional Analysis/Insights
The diaphragm pacing device market is analysed and market size insights and trends are provided by country, product and application as referenced above.
The countries covered in the diaphragm pacing device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the diaphragm pacing device market due to high disposable income and rising healthcare expenditure, rising prevalence of breathing disorders including amyotrophic lateral sclerosis, sleep apnea and spinal cord injuries in the region. Furthermore, the improving healthcare expenditure and the growing disposable incomes of patients are expected to contribute to market growth in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing R&D investments to develop technologically advanced healthcare infrastructure. Additionally, favourable government regulations also surge the market growth in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The diaphragm pacing device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for diaphragm pacing device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diaphragm pacing device market. The data is available for historic period 2010-2020.
Competitive Landscape and Diaphragm Pacing Device Market Share Analysis
The diaphragm pacing device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to diaphragm pacing device market.
Some of the major players operating in the diaphragm pacing device market are:
- Unicare (U.S.)
- Mayo Foundation for Medical Education and Research (MFMER) (U.S.)
- Wellmark Inc. (U.S.)
- Avery Biomedical Devices, Inc. (U.S.)
- Lungpacer Medical Inc (Canada)
- Diaphragm Direct (U.S.)
- Splashtop Inc (U.S.)
- DYI SHENG INDUSTRY CO.LTD (Taiwan)
- Ningbo Yokey Precision Technology Co. Ltd (China)
- ZHONGDE (BEIJING) MACHINERY EQUIPMENT CO, LTD (China)
- TexRAD Limited (U.S.)
- Arrow Safety Device (U.S.)
- Device Technologies, Inc (U.S.)
- Lungpacer Medical Inc. (Canada)
- Avery Biomedical Devices, Inc. (U.S.)
- Synapse Biomedical (U.S.)
- Atrotech (Germany)
- Medtronic (Ireland)
SKU-